[go: up one dir, main page]

IL193282A - Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases - Google Patents

Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases

Info

Publication number
IL193282A
IL193282A IL193282A IL19328208A IL193282A IL 193282 A IL193282 A IL 193282A IL 193282 A IL193282 A IL 193282A IL 19328208 A IL19328208 A IL 19328208A IL 193282 A IL193282 A IL 193282A
Authority
IL
Israel
Prior art keywords
csf
chimeric protein
lysosomal storage
storage diseases
therapeutic enzyme
Prior art date
Application number
IL193282A
Other languages
Hebrew (he)
Other versions
IL193282A0 (en
Inventor
Anthony Futerman
Naftali Stern
Ruth Navon
Ari Zimran
Etty Osher
Original Assignee
Yeda Res & Dev
Medical Res And Infrastructure Fund Of The Tel Aviv Sourasky Medical Ct
Anthony Futerman
Univ Ramot
Naftali Stern
Ruth Navon
Ari Zimran
Etty Osher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2007/000152 external-priority patent/WO2007091250A2/en
Application filed by Yeda Res & Dev, Medical Res And Infrastructure Fund Of The Tel Aviv Sourasky Medical Ct, Anthony Futerman, Univ Ramot, Naftali Stern, Ruth Navon, Ari Zimran, Etty Osher filed Critical Yeda Res & Dev
Priority to IL193282A priority Critical patent/IL193282A/en
Publication of IL193282A0 publication Critical patent/IL193282A0/en
Publication of IL193282A publication Critical patent/IL193282A/en

Links

IL193282A 2006-02-06 2008-08-06 Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases IL193282A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL193282A IL193282A (en) 2006-02-06 2008-08-06 Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76516706P 2006-02-06 2006-02-06
PCT/IL2007/000152 WO2007091250A2 (en) 2006-02-06 2007-02-06 Enzyme replacement therapy for treating lysosomal storage diseases
IL193282A IL193282A (en) 2006-02-06 2008-08-06 Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases

Publications (2)

Publication Number Publication Date
IL193282A0 IL193282A0 (en) 2009-02-11
IL193282A true IL193282A (en) 2013-04-30

Family

ID=42104295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193282A IL193282A (en) 2006-02-06 2008-08-06 Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases

Country Status (1)

Country Link
IL (1) IL193282A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3833689A4 (en) * 2018-08-07 2022-05-25 Armagen, Inc. Methods and compositions for increasing the activity in the cns of hexosaminidase a, acid sphingomyelinase, and palmitoyl-protein thioesterase 1
US12043661B2 (en) 2009-10-09 2024-07-23 Armagen, Inc. Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12043661B2 (en) 2009-10-09 2024-07-23 Armagen, Inc. Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
EP3833689A4 (en) * 2018-08-07 2022-05-25 Armagen, Inc. Methods and compositions for increasing the activity in the cns of hexosaminidase a, acid sphingomyelinase, and palmitoyl-protein thioesterase 1

Also Published As

Publication number Publication date
IL193282A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
IL266734B (en) Gene therapy for lysosomal storage diseases
EP2155197A4 (en) Treatment of lysosomal storage diseases
WO2007091250A3 (en) Enzyme replacement therapy for treating lysosomal storage diseases
SI2044111T1 (en) Targeting complement factor h for treatment of diseases
EP2019649A4 (en) Compositions and methods for treating or preventing diseases of body passageways
ZA200801511B (en) Novel diazaspiroalkanes and their use for treatment of CCR8 medicated diseases
IL193473A0 (en) Amide derivatives and their application for the treatment of g protein related diseases
LT2666476T (en) Intraventricular enzyme delivery for lysosomal storage diseases
IL193289A0 (en) Compositions and methods for treating lysosomal storage diseases
IL193500A (en) Pharmaceutical compositions comprising n-oxide of vinca alkaloid analog for treating hyper-proliferative diseases
EP2091335A4 (en) Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
IL198723A0 (en) Methods and compositions for therapeutic treatment
HK1171972A1 (en) Methods and products for treatment of diseases
EP2049899A4 (en) Methods to prevent and treat diseases
EP2063902A4 (en) Therapeutic cell medicine comprising skin tissue derived stem cell
EP2001488A4 (en) Prevention and treatment of cancer and other diseases
IL197125A0 (en) Drug combinations for treating airway diseases
IL193282A (en) Chimeric protein of a therapeutic enzyme and g-csf for treating lysosomal storage diseases
PT2572724T (en) Treatment of fibrosis and liver diseases
ZA200900543B (en) Compositions and methods for the treatment of mucormycosis and other fungal diseases
IL198605A0 (en) Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
GB0602168D0 (en) Therapeutic preparations for the therapy of dermatoses
IL178853A0 (en) Tar composition for the treatment of skin diseases
AU2006902723A0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees
KB Patent renewed
KB Patent renewed
KB Patent renewed